Nanotheranostics Revolutionizing Gene Therapy: Emerging Applications in Gene Delivery Enhancement

Nanotheranostics—where nanoscale materials serve both diagnostic and therapeutic functions—are rapidly transforming gene therapy by tackling critical delivery challenges. This review explores the design and engineering of various nanoparticle systems (lipid-based, polymeric, inorganic, and hybrid) to enhance stability, targeting, and endosomal escape of genetic payloads. We discuss how real-time imaging capabilities integrated into these platforms enable precise localization and controlled release of genes, improving treatment efficacy while reducing off-target effects. Key strategies to overcome delivery barriers (such as proton sponge effect and photothermal disruption) and to achieve nuclear localization are highlighted, along with recent advances in stimuli-responsive systems that facilitate spatiotemporal control of gene expression. Clinical trials and preclinical studies demonstrate the expanding role of nanotheranostics in managing cancer, inherited disorders, and cardiovascular and neurological diseases. We further address regulatory and manufacturing hurdles that must be overcome for the widespread clinical adoption of nanoparticle-based gene therapies. By synthesizing recent progress and ongoing challenges, this review underscores the transformative potential of nanotheranostics for effective, targeted, and image-guided gene delivery.

• Publication year

  2025

• Venue

  Journal of Nanotheranostics

• Publication date

  2025-04-09

• Fields of study

  Not labeled

• Identifiers
  DOI 10.3390/jnt6020010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent Advances in Biocatalytic and Chemoenzymatic Synthesis of Oligonucleotides

  2025cited by this paper
• Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy

  2025cited by this paper
• Iron Oxide Nanoparticles: The Versatility of the Magnetic and Functionalized Nanomaterials in Targeting Drugs, and Gene Deliveries with Effectual Magnetofection

  2024cited by this paper
• Cellular Imaging and Time-Domain FLIM Studies of Meso-Tetraphenylporphine Disulfonate as a Photosensitising Agent in 2D and 3D Models

  2024cited by this paper
• Design, Characterization, and Evaluation of Textile Systems and Coatings for Sports Use: Applications in the Design of High-Thermal Comfort Wearables

  2024cited by this paper
• Aptamer-guided graphene oxide quantum dots for targeted suicide gene therapy in an organoid model of luminal breast cancer

  2024cited by this paper
• Nanoparticle Targeting Strategies for Lipid and Polymer‐Based Gene Delivery to Immune Cells In Vivo

  2024cited by this paper
• Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies

  2024cited by this paper
• Application of Photoactive Compounds in Cancer Theranostics: Review on Recent Trends from Photoactive Chemistry to Artificial Intelligence

  2024cited by this paper
• Recent developments of polymeric delivery systems in gene therapeutics

  2024cited by this paper
• An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial

  2024cited by this paper
• Polymers as Efficient Non-Viral Gene Delivery Vectors: The Role of the Chemical and Physical Architecture of Macromolecules

  2024cited by this paper
• Advancements in nanoparticles-based therapies for biomedical applications

  2024cited by this paper
• Clinical applications and therapeutic potentials of advanced nanoparticles: a comprehensive review on completed human clinical trials

  2024cited by this paper
• Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association

  2024cited by this paper
• Innovative hybrid nanostructures: pioneering advances in modern therapy

  2024cited by this paper
• Exploration of Ultrasound‐Sensitive Biomaterials in Cancer Theranostics

  2024cited by this paper
• Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma

  2024cited by this paper
• Micelle-engineered nanoplatforms for precision oncology

  2024cited by this paper
• Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation

  2024cited by this paper
• Redefining vascular repair: revealing cellular responses on PEUU—gelatin electrospun vascular grafts for endothelialization and immune responses on in vitro models

  2024cited by this paper
• Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa

  2024cited by this paper
• Understanding the complexity of p53 in a new era of tumor suppression.

  2024cited by this paper
• Focused ultrasound gene delivery for the treatment of neurological disorders.

  2024cited by this paper
• Recent nanotheranostic approaches in cancer research

  2024cited by this paper
• Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia

  2024cited by this paper
• Crossing the Threshold of Therapeutic Hope for Patients With PKP2 Arrhythmogenic Cardiomyopathy.

  2024cited by this paper
• Role of gene therapy in sickle cell disease.

  2024cited by this paper
• Functional inorganic nanoparticles in cancer: Biomarker detection, imaging, and therapy

  2024cited by this paper
• Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.

  2024cited by this paper
• Production and purification of outer membrane vesicles encapsulating green fluorescent protein from Escherichia coli: a step towards scalable OMV technologies

  2024cited by this paper
• Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care

  2024cited by this paper
• Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors

  2024cited by this paper
• Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.

  2024cited by this paper
• Approval of the first TCR-based cell therapy.

  2024cited by this paper
• Endosomal escape in magnetic nanostructures: Recent advances and future perspectives

  2024cited by this paper
• Recent Progress in the Endosomal Escape Mechanism and Chemical Structures of Polycations for Nucleic Acid Delivery.

  2024cited by this paper
• Gene therapy for ultrarare diseases: a geneticist’s perspective

  2024cited by this paper
• Enhancing Magnetic Micro- and Nanoparticle Separation with a Cost-Effective Microfluidic Device Fabricated by Laser Ablation of PMMA

  2024cited by this paper
• Engineering Sonosensitizer-Derived Nanotheranostics for Augmented Sonodynamic Therapy.

  2024cited by this paper
• Achieving Endo/Lysosomal Escape Using Smart Nanosystems for Efficient Cellular Delivery

  2024cited by this paper
• Stimulus-Responsive Nanodelivery and Release Systems for Cancer Gene Therapy: Efficacy Improvement Strategies

  2024cited by this paper
• Assessment of CRISPRa-mediated gdnf overexpression in an In vitro Parkinson’s disease model

  2024cited by this paper
• Zweifach–Fung Microfluidic Device for Efficient Microparticle Separation: Cost-Effective Fabrication Using CO2 Laser-Ablated PMMA

  2024cited by this paper
• Utility of sulfachloropyridazine in the synthesis of novel anticancer agents as antiangiogenic and apoptotic inducers.

  2024cited by this paper
• Gene therapy in pediatrics - Clinical studies and approved drugs (as of 2023).

  2024cited by this paper
• Ultrasound image-guided cancer gene therapy using iRGD dual-targeted magnetic cationic microbubbles.

  2024cited by this paper
• Theranostics advances in the treatment and diagnosis of neurological and neurosurgical diseases.

  2024cited by this paper
• Real-Time Magnetic Resonance Imaging During Convective Gene Therapy Perfusion of the Brain.

  2024cited by this paper
• Recent insights into the functions and mechanisms of antisense RNA: emerging applications in cancer therapy and precision medicine

  2024cited by this paper
• The FDA approval of delandistrogene moxeparvovec-rokl for Duchenne muscular dystrophy: a critical examination of the evidence and regulatory process

  2024cited by this paper
• Rational design of polymeric micelles for targeted therapeutic delivery

  2024cited by this paper
• Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases

  2024cited by this paper
• Respiratory Toxicology of Graphene-Based Nanomaterials: A Review

  2024cited by this paper
• Imaging-Assisted Antisense Oligonucleotide Delivery for Tumor-Targeted Gene Therapy

  2024cited by this paper
• 54O Health state impacts of afamitresgene autoleucel (afami-cel) in advanced synovial sarcoma and myxoid/round cell liposarcoma: SPEARHEAD-1 cohort 1

  2024cited by this paper
• pH regulators and their inhibitors in tumor microenvironment.

  2024cited by this paper
• Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development

  2024cited by this paper
• The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based Therapies

  2024cited by this paper
• Emerging trends in nano-carrier based gene delivery systems for targeted cancer therapy

  2024cited by this paper
• Nanoplatform-Based In Vivo Gene Delivery Systems for Cancer Therapy.

  2024cited by this paper
• Recent advances in the design of organic photothermal agents for cancer treatment: A review

  2024cited by this paper
• Theranostics and artificial intelligence: new frontiers in personalized medicine

  2024cited by this paper
• Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery

  2023cited by this paper
• Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy

  2023cited by this paper
• The Impact of Yeast Encapsulation in Wort Fermentation and Beer Flavor Profile

  2023cited by this paper
• Etranacogene Dezaparvovec: First Approval

  2023cited by this paper
• Hemophilia treatment innovation: 50 years of progress and more to come.

  2023cited by this paper
• Low-cost inertial microfluidic device for microparticle separation: A laser-Ablated PMMA lab-on-a-chip approach without a cleanroom

  2023cited by this paper
• Thermosensitive Cationic Magnetic Liposomes for Thermoresponsive Delivery of CPT-11 and SLP2 shRNA in Glioblastoma Treatment

  2023cited by this paper
• Suicide Gene Delivery by Morphology-Adaptable Enantiomeric Peptide Assemblies for Combined Ovarian Cancer Therapy.

  2023cited by this paper
• Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics

  2023cited by this paper
• Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment

  2023cited by this paper
• Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation

  2023cited by this paper
• Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001.

  2023cited by this paper
• PCR-based analytics of gene therapies using adeno-associated virus vectors: Considerations for cGMP method development

  2023cited by this paper
• CRISPR/Cas9 therapeutics: progress and prospects

  2023cited by this paper
• Current status of Cancer Nanotheranostics: Emerging strategies for cancer management

  2023cited by this paper
• Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug Delivery

  2023cited by this paper
• Outcome after chimeric antigen receptor (CAR) T‐cell therapy failure in large B‐cell lymphomas

  2023cited by this paper
• Classification and growth rate of chorioretinal atrophy after voretigene neparvovec-rzyl for RPE65-mediated retinal degeneration.

  2023cited by this paper
• Polyethylenimine (PEI) in gene therapy: Current status and clinical applications.

  2023cited by this paper
• Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology

  2023cited by this paper
• Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

  2023cited by this paper
• Stem cell–nanomedicine system as a theranostic bio-gadolinium agent for targeted neutron capture cancer therapy

  2023cited by this paper
• Magnetic Resonance Imaging and Iron-oxide Nanoparticles in the era of Personalized Medicine

  2023cited by this paper
• Outcomes of Arterial Bypass With the Human Acellular Vessel for Chronic Limb-Threatening Ischemia Performed Under the FDA Expanded Access Program.

  2023cited by this paper
• Nanomedicine in cancer therapy

  2023cited by this paper
• A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements.

  2023cited by this paper
• Donislecel-the first approved pancreatic islet cell therapy medication for type 1 diabetes: a letter to the editor

  2023cited by this paper
• Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models

  2023cited by this paper
• Nanoparticle Based Cardiac Specific Drug Delivery

  2023cited by this paper
• Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

  2023cited by this paper
• Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery

  2023cited by this paper
• Selective organ targeting nanoparticles: from design to clinical translation.

  2023cited by this paper
• Nanotheranostics: Platforms, Current Applications, and Mechanisms of Targeting in Breast and Prostate Cancers

  2023cited by this paper
• Biomembrane-wrapped gene delivery nanoparticles for cancer therapy

  2023cited by this paper
• Gene therapy in cancer

  2023cited by this paper
• Nuclear Delivery of Nanoparticle-Based Drug Delivery Systems by Nuclear Localization Signals

  2023cited by this paper
• Human and environmental impacts of nanoparticles: a scoping review of the current literature

  2023cited by this paper

• From surface chemistry to nuclear targeting: The multifaceted challenge of genetic delivery via inorganic nanoparticles

  2026cites this paper
• CRISPR/Cas9 genome editing-based preclinical theranostics, biomarkers and drug delivery systems for cancer applications.

  2026cites this paper
• From Words to Frameworks: Transformer Models for Metal–Organic Framework Design in Nanotheranostics

  2026cites this paper
• Neuropeptide Y as a multifaceted modulator of neuroplasticity, Neuroinflammation, and HPA axis dysregulation: Perceptions into treatment-resistant depression.

  2025cites this paper
• Advanced nanotheranostic approaches for targeted glioblastoma treatment: a synergistic fusion of CRISPR-Cas gene editing, AI-driven tumor profiling, and BBB-modulation

  2025cites this paper
• Role of Radioiodine in Cancer Therapy: A Review of the Design and Challenges in Selecting Radioligands from Natural Sources

  2025cites this paper
• Magnetoliposomes for nanomedicine: synthesis, characterization, and applications in drug, gene, and peptide delivery

  2025cites this paper
• Smart pH-Responsive polymers in biomedical Applications: Nanoparticles, hydrogels, and emerging hybrid platforms

  2025cites this paper
• Intranasal drug delivery for brain tumors: Promise and challenges

  2025cites this paper
• Nanotheranostics: emerging nanomachines as pharmacotherapeutics

  2025cites this paper
• Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K

  2025cites this paper
• A mathematical phase field model predicts superparamagnetic nanoparticle accelerated fusion of HeLa spheroids for field guided biofabrication

  2025cites this paper
• Potential of Nerve Growth Factor (NGF)- and Brain-Derived Neurotrophic Factor (BDNF)-Targeted Gene Therapy for Alzheimer’s Disease: A Narrative Review

  2025cites this paper